Examining Maintenance Treatment Options in CIDP
The Gene Messenger: Advancing Neurological Gene Therapy
Michael Kaplitt, MD, PhD
PeerThe Network Effect: Analyzing Brain Structures to Treat Depression
Conor Liston, MD, PhD
PeerSupporting Adult Patients With Anti-AChR Antibody Positive gMG in Their Treatment Journeys: A Look at a Program
Andrew Gordon, MD
PeerDiving into a Treatment for Seizure Clusters Through Patient Case Studies
David Burdette, MD
PeerExamining 2 Treatment Options for Anti-AChR Antibody Positive gMG: An Overview of the Trial Designs
Charulatha P. Nagar, MD
PeerEmpower Your Patients With a Seizure Action Plan
Lawrence Hirsch, MD
PeerTreating Anti-AChR Antibody Positive gMG: Clinical Trials for 2 Treatment Options
Tuan H. Vu, MD
PeerUnderstanding the Dosing and Administration of 2 Treatment Options for Anti-AChR Antibody Positive gMG
Jennifer Buczyner, MD
PeerUnderstanding the Key Role of FcRn in Anti-AChR Antibody Positive gMG
Nicholas J. Silvestri, MD, FAAN
PeerIdentifying Appropriate Patients for Acute Seizure Treatment
Sheryl Haut, MD
PeerAdvances in Acute Seizure Treatment Options
Lawrence Hirsch, MD
PeerUnderstanding Individualized Treatment Goals for gMG
Beth Stein, MD
Peer